# Vertex Stock Probability of Future Stock Price Finishing Over 312.98

VRTX | Stock | ## USD 312.98 3.18 1.01% |

Vertex |

### Closest to current price Vertex long CALL Option Payoff at Expiration

Also, please take a look at Vertex Pharmaceutic Backtesting, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Volatility, Vertex Pharmaceutic History as well as Vertex Pharmaceutic Performance. Please specify Vertex Pharmaceutic time horizon, a valid symbol (red box) and a target price (blue box) you would like Vertex Pharmaceutic odds to be computed.

## Vertex Pharmaceutic Target Price Odds to finish over 312.98

The tendency of Vertex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.

Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |

312.98 | 90 days | 312.98 | about 8.38 |

Based on a normal probability distribution, the odds of Vertex Pharmaceutic to move above the current price in 90 days from now is about 8.38 (This Vertex Pharmaceutic probability density function shows the probability of Vertex Stock to fall within a particular range of prices over 90 days) .

Given the investment horizon of 90 days Vertex Pharmaceutic has a beta of 0.82. This entails as returns on the market go up, Vertex Pharmaceutic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vertex Pharmaceutic will be expected to be much smaller as well. Additionally The company has an alpha of 0.0734, implying that it can generate a 0.0734 percent excess return over DOW after adjusting for the inherited market risk (beta). Vertex Pharmaceutic Price Density |

Price |

## Predictive Modules for Vertex Pharmaceutic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vertex Pharmaceutic. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vertex Pharmaceutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vertex Pharmaceutic in the context of predictive analytics.

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceutic. Your research has to be compared to or analyzed against Vertex Pharmaceutic's peers to derive any actionable benefits. When done correctly, Vertex Pharmaceutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Vertex Pharmaceutic.

## Vertex Pharmaceutic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vertex Pharmaceutic is not an exception. The market had few large corrections towards the Vertex Pharmaceutic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vertex Pharmaceutic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vertex Pharmaceutic within the framework of very fundamental risk indicators.α | Alpha over DOW | 0.07 | |

β | Beta against DOW | 0.82 | |

σ | Overall volatility | 11.68 | |

Ir | Information ratio | 0.028218 |

## Vertex Pharmaceutic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vertex Pharmaceutic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vertex Pharmaceutic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Vertex Pharmaceutic is unlikely to experience financial distress in the next 2 years | |

Over 95.0% of the company outstanding shares are owned by institutional investors | |

Latest headline from MacroaxisInsider: Acquisition by Winger Dennis L of 20000 shares of Vertex Pharmaceutic subject to Rule 16b-3 |

## Vertex Pharmaceutic Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vertex Stock often depends not only on the future outlook of the current and potential Vertex Pharmaceutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceutic's indicators that are reflective of the short sentiment are summarized in the table below.

Shares Percent Shares Out | 1.10% | |

Short Percent Of Float | 1.11% | |

Float Shares | 256.1M | |

Average Daily Volume Last 10 Day | 1.37M | |

Shares Short Prior Month | 3.11M | |

Average Daily Volume In Three Month | 1.39M | |

Date Short Interest | 31st of October 2022 |

## Vertex Pharmaceutic Technical Analysis

Vertex Pharmaceutic's future price can be derived by breaking down and analyzing its technical indicators over time. Vertex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vertex Pharmaceutic. In general, you should focus on analyzing Vertex Stock price patterns and their correlations with different microeconomic environments and drivers.

Cycle Indicators | ||

Math Operators | ||

Math Transform | ||

Momentum Indicators | ||

Overlap Studies | ||

Pattern Recognition | ||

Price Transform | ||

Statistic Functions | ||

Volatility Indicators | ||

Volume Indicators |

## Vertex Pharmaceutic Predictive Forecast Models

Vertex Pharmaceutic time-series forecasting models is one of many Vertex Pharmaceutic's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vertex Pharmaceutic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

## Things to note about Vertex Pharmaceutic

Checking the ongoing alerts about Vertex Pharmaceutic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vertex Pharmaceutic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Vertex Pharmaceutic is unlikely to experience financial distress in the next 2 years | |

Over 95.0% of the company outstanding shares are owned by institutional investors | |

Latest headline from MacroaxisInsider: Acquisition by Winger Dennis L of 20000 shares of Vertex Pharmaceutic subject to Rule 16b-3 |

Also, please take a look at Vertex Pharmaceutic Backtesting, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Volatility, Vertex Pharmaceutic History as well as Vertex Pharmaceutic Performance. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

## Complementary Tools for analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.

Insider ScreenerFind insiders across different sectors to evaluate their impact on performance | Go | |

Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | Go | |

Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk | Go | |

Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk | Go | |

Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | Go | |

Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | Go | |

Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios | Go | |

Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios | Go | |

Analyst RecommendationsAnalyst recommendations and target price estimates broken down by several categories | Go | |

Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | Go | |

Insider ScreenerFind insiders across different sectors to evaluate their impact on performance | Go | |

Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm | Go |

Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 0.095 | Market Capitalization 81.7 B | Quarterly Revenue Growth YOY 0.18 | Return On Assets 0.14 | Return On Equity 0.29 |

The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.